A flat-fee pioneer drifts to the top of the price board
The provider that popularized flat-fee compounded GLP-1 now prices at the higher end of our tracker, a reminder that 'the original' is not automatically the cheapest anymore.
Henry Meds helped popularize the flat-fee compounded GLP-1 model. This cycle its line drifted to the higher end of our tracker — a reminder that being first to a pricing model doesn't lock in the lowest price forever.
Newer entrants have undercut the original flat-fee names while keeping the same simple, one-price structure. The brand equity is real, but readers paying a premium for it should know they're paying for the name, not for a rate advantage.
If a simple, well-known flat-fee program is worth a few dollars to you, it still delivers. If price is the deciding factor, the board has cheaper honest options.
Go deeper: Read the Henry Meds brief, or see the full best GLP-1 providers board and this week's price tracker.
This is a dated market observation, current as of Jun 24, 2026, and is health and consumer information for education — not medical advice. Prices and supply status change; confirm at the source. See our disclosure.